4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile

C102H140BBrN26O15Si2 — CID 161491595

IUPAC4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile
SMILESCC(C)(C)OC(=O)N1CCC[C@@H](Nc2c(B3OC(C)(C)C(C)(C)O3)cnc3c2ccn3COCC[Si](C)(C)C)C1.COc1nccc(-c2cnc3[nH]ccc3c2N[C@@H]2CCCN(C(=O)CC#N)C2)n1.COc1nccc(-c2cnc3[nH]ccc3c2N[C@@H]2CCCNC2)n1.COc1nccc(-c2cnc3c(ccn3COCC[Si](C)(C)C)c2N[C@@H]2CCCN(C(=O)OC(C)(C)C)C2)n1.COc1nccc(Br)n1.N#CCC(=O)O
InChIInChI=1S/C29H49BN4O5Si.C28H42N6O4Si.C20H21N7O2.C17H20N6O.C5H5BrN2O.C3H3NO2/c1-27(2,3)37-26(35)33-14-11-12-21(19-33)32-24-22-13-15-34(20-36-16-17-40(8,9)10)25(22)31-18-23(24)30-38-28(4,5)29(6,7)39-30;1-28(2,3)38-27(35)33-13-8-9-20(18-33)31-24-21-11-14-34(19-37-15-16-39(5,6)7)25(21)30-17-22(24)23-10-12-29-26(32-23)36-4;1-29-20-23-9-6-16(26-20)15-11-24-19-14(5-8-22-19)18(15)25-13-3-2-10-27(12-13)17(28)4-7-21;1-24-17-20-8-5-14(23-17)13-10-21-16-12(4-7-19-16)15(13)22-11-3-2-6-18-9-11;1-9-5-7-3-2-4(6)8-5;4-2-1-3(5)6/h13,15,18,21H,11-12,14,16-17,19-20H2,1-10H3,(H,31,32);10-12,14,17,20H,8-9,13,15-16,18-19H2,1-7H3,(H,30,31);5-6,8-9,11,13H,2-4,10,12H2,1H3,(H2,22,24,25);4-5,7-8,10-11,18H,2-3,6,9H2,1H3,(H2,19,21,22);2-3H,1H3;1H2,(H,5,6)/t21-;20-;13-;11-;;/m1111../s1
InChIKeyWFRIAKPSUWDZEB-SUFBOUAISA-N
MW2117.30 g/mol
LogP16.85
Rot. Bonds28

About 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile

4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile (PubChem CID 161491595) has the molecular formula C102H140BBrN26O15Si2 and a molecular weight of 2117.30 g/mol. Its IUPAC name is 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile.

Molecular Properties

Compound Name4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile
PubChem CID161491595
Molecular FormulaC102H140BBrN26O15Si2
Molecular Weight2117.30 g/mol
Exact Mass2114.98
IUPAC Name4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile
SMILESCC(C)(C)OC(=O)N1CCC[C@@H](Nc2c(B3OC(C)(C)C(C)(C)O3)cnc3c2ccn3COCC[Si](C)(C)C)C1.COc1nccc(-c2cnc3[nH]ccc3c2N[C@@H]2CCCN(C(=O)CC#N)C2)n1.COc1nccc(-c2cnc3[nH]ccc3c2N[C@@H]2CCCNC2)n1.COc1nccc(-c2cnc3c(ccn3COCC[Si](C)(C)C)c2N[C@@H]2CCCN(C(=O)OC(C)(C)C)C2)n1.COc1nccc(Br)n1.N#CCC(=O)O
InChIInChI=1S/C29H49BN4O5Si.C28H42N6O4Si.C20H21N7O2.C17H20N6O.C5H5BrN2O.C3H3NO2/c1-27(2,3)37-26(35)33-14-11-12-21(19-33)32-24-22-13-15-34(20-36-16-17-40(8,9)10)25(22)31-18-23(24)30-38-28(4,5)29(6,7)39-30;1-28(2,3)38-27(35)33-13-8-9-20(18-33)31-24-21-11-14-34(19-37-15-16-39(5,6)7)25(21)30-17-22(24)23-10-12-29-26(32-23)36-4;1-29-20-23-9-6-16(26-20)15-11-24-19-14(5-8-22-19)18(15)25-13-3-2-10-27(12-13)17(28)4-7-21;1-24-17-20-8-5-14(23-17)13-10-21-16-12(4-7-19-16)15(13)22-11-3-2-6-18-9-11;1-9-5-7-3-2-4(6)8-5;4-2-1-3(5)6/h13,15,18,21H,11-12,14,16-17,19-20H2,1-10H3,(H,31,32);10-12,14,17,20H,8-9,13,15-16,18-19H2,1-7H3,(H,30,31);5-6,8-9,11,13H,2-4,10,12H2,1H3,(H2,22,24,25);4-5,7-8,10-11,18H,2-3,6,9H2,1H3,(H2,19,21,22);2-3H,1H3;1H2,(H,5,6)/t21-;20-;13-;11-;;/m1111../s1
InChIKeyWFRIAKPSUWDZEB-SUFBOUAISA-N
XLogP16.85
TPSA494.38 Ų
H-Bond Donors8
H-Bond Acceptors35
Rotatable Bonds28
Heavy Atoms147
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002117.30
LogP ≤ 516.85
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1035

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile?
The IUPAC name of 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile (CID 161491595) is 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile.
What is the SMILES notation for 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile?
The canonical SMILES for 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile is CC(C)(C)OC(=O)N1CCC[C@@H](Nc2c(B3OC(C)(C)C(C)(C)O3)cnc3c2ccn3COCC[Si](C)(C)C)C1.COc1nccc(-c2cnc3[nH]ccc3c2N[C@@H]2CCCN(C(=O)CC#N)C2)n1.COc1nccc(-c2cnc3[nH]ccc3c2N[C@@H]2CCCNC2)n1.COc1nccc(-c2cnc3c(ccn3COCC[Si](C)(C)C)c2N[C@@H]2CCCN(C(=O)OC(C)(C)C)C2)n1.COc1nccc(Br)n1.N#CCC(=O)O.
What is the InChIKey of 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile?
The InChIKey is WFRIAKPSUWDZEB-SUFBOUAISA-N. The full InChI is InChI=1S/C29H49BN4O5Si.C28H42N6O4Si.C20H21N7O2.C17H20N6O.C5H5BrN2O.C3H3NO2/c1-27(2,3)37-26(35)33-14-11-12-21(19-33)32-24-22-13-15-34(20-36-16-17-40(8,9)10)25(22)31-18-23(24)30-38-28(4,5)29(6,7)39-30;1-28(2,3)38-27(35)33-13-8-9-20(18-33)31-24-21-11-14-34(19-37-15-16-39(5,6)7)25(21)30-17-22(24)23-10-12-29-26(32-23)36-4;1-29-20-23-9-6-16(26-20)15-11-24-19-14(5-8-22-19)18(15)25-13-3-2-10-27(12-13)17(28)4-7-21;1-24-17-20-8-5-14(23-17)13-10-21-16-12(4-7-19-16)15(13)22-11-3-2-6-18-9-11;1-9-5-7-3-2-4(6)8-5;4-2-1-3(5)6/h13,15,18,21H,11-12,14,16-17,19-20H2,1-10H3,(H,31,32);10-12,14,17,20H,8-9,13,15-16,18-19H2,1-7H3,(H,30,31);5-6,8-9,11,13H,2-4,10,12H2,1H3,(H2,22,24,25);4-5,7-8,10-11,18H,2-3,6,9H2,1H3,(H2,19,21,22);2-3H,1H3;1H2,(H,5,6)/t21-;20-;13-;11-;;/m1111../s1.
What are the key properties of 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile?
4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile has a molecular weight of 2117.30 g/mol, XLogP of 16.85, 28 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for 4-bromo-2-methoxypyrimidine;tert-butyl (3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;tert-butyl (3R)-3-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2-trimethylsilylethoxymethyl)pyrrolo[2,3-b]pyridin-4-yl]amino]piperidine-1-carboxylate;2-cyanoacetic acid;5-(2-methoxypyrimidin-4-yl)-N-[(3R)-piperidin-3-yl]-1H-pyrrolo[2,3-b]pyridin-4-amine;3-[(3R)-3-[[5-(2-methoxypyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-yl]amino]piperidin-1-yl]-3-oxopropanenitrile is sourced from PubChem (CID 161491595), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).